scholarly article | Q13442814 |
P50 | author | Bruno M Grande | Q57292745 |
Rebecca Deyell | Q58141427 | ||
Daniel Fornika | Q59116660 | ||
Rod Rassekh | Q55459518 | ||
P2093 | author name string | David G Huntsman | |
Nathalie A Johnson | |||
Ryan D Morin | |||
Stephen Yu | |||
Luca Cavallone | |||
Miguel Alcaide | |||
Mark Basik | |||
Gerald Batist | |||
Sarah Arthur | |||
Adriana Aguilar | |||
Kevin Bushell | |||
Suzan McNamara | |||
Jordan Davidson | |||
Marco Albuquerque | |||
Mathilde Couetoux du Tertre | |||
P2860 | cites work | Cancer: hunting rare somatic mutations | Q89085234 |
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma | Q37150016 | ||
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance | Q38249332 | ||
Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies | Q38390077 | ||
Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies. | Q38651951 | ||
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR. | Q38886040 | ||
Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. | Q40130589 | ||
Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors | Q40236118 | ||
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer | Q40364937 | ||
Mutant DNA quantification by digital PCR can be confounded by heating during DNA fragmentation | Q40366339 | ||
Screening for circulating RAS/RAF mutations by multiplex digital PCR. | Q40374225 | ||
Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma | Q40391622 | ||
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. | Q41066322 | ||
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer | Q26746010 | ||
Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer | Q26775376 | ||
"Liquid biopsy"-ctDNA detection with great potential and challenges | Q26779222 | ||
Detection of circulating tumor DNA in early- and late-stage human malignancies | Q29615778 | ||
Detecting ultralow-frequency mutations by Duplex Sequencing | Q30413211 | ||
Streamlined analysis of duplex sequencing data with Du Novo | Q31124112 | ||
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. | Q33590850 | ||
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. | Q33663019 | ||
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. | Q34278191 | ||
Detection of ultra-rare mutations by next-generation sequencing | Q34291814 | ||
Liquid biopsy: monitoring cancer-genetics in the blood | Q34356149 | ||
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types | Q34457638 | ||
Real-time liquid biopsies become a reality in cancer treatment | Q34468931 | ||
Integrated digital error suppression for improved detection of circulating tumor DNA | Q34520008 | ||
Circulating tumor-derived DNA is shorter than somatic DNA in plasma. | Q35212453 | ||
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients | Q35212779 | ||
Sequencing small genomic targets with high efficiency and extreme accuracy. | Q35554760 | ||
Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report | Q35916214 | ||
Ultra-precise detection of mutations by droplet-based amplification of circularized DNA. | Q35951516 | ||
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease | Q36000803 | ||
BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase | Q36026747 | ||
Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations | Q36077810 | ||
Targeted single molecule mutation detection with massively parallel sequencing | Q36588964 | ||
Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR. | Q36853563 | ||
Utility of KRAS mutation detection using circulating cell-free DNA from patients with colorectal cancer | Q37098291 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 10574 | |
P577 | publication date | 2017-09-05 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits | |
P478 | volume | 7 |
Q48178985 | A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications |
Q53836887 | Detecting Rare Mutations and DNA Damage with Sequencing-Based Methods. |
Q92283498 | High efficiency error suppression for accurate detection of low-frequency variants |
Q88225399 | Molecular Profiling of Liquid Biopsy Samples for Precision Medicine |
Q60046573 | Rapid and highly-specific generation of targeted DNA sequencing libraries enabled by linking capture probes with universal primers |
Search more.